Publication | Closed Access

A Risk-adapted Study of Cisplatin and Etoposide, with or Without Ifosfamide, in Patients with Metastatic Seminoma: Results of the GETUG S99 Multicenter Prospective Study

UrologyMetastatic SeminomaGenitourinary CancerMedicinePathologyMolecular OncologyCancer TreatmentOncologyRadiation OncologyCancer ResearchRisk-adapted Study